161 related articles for article (PubMed ID: 38570592)
21. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
[TBL] [Abstract][Full Text] [Related]
22. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
23. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
Lv P; Xue Y
Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
[TBL] [Abstract][Full Text] [Related]
24. Delving into the Role of lncRNAs in Papillary Thyroid Cancer: Upregulation of LINC00887 Promotes Cell Proliferation, Growth and Invasion.
Tous C; Muñoz-Redondo C; Gavilán A; Bravo-Gil N; Baco-Antón F; Navarro-González E; Antiñolo G; Borrego S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338866
[TBL] [Abstract][Full Text] [Related]
25. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
26. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
Bi W; Huang J; Nie C; Liu B; He G; Han J; Pang R; Ding Z; Xu J; Zhang J
J Exp Clin Cancer Res; 2018 Nov; 37(1):275. PubMed ID: 30424816
[TBL] [Abstract][Full Text] [Related]
27. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
28. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
Oncol Rep; 2015 Oct; 34(4):2202-10. PubMed ID: 26239517
[TBL] [Abstract][Full Text] [Related]
29. Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells.
Allegri L; Capriglione F; Maggisano V; Damante G; Baldan F
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360846
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of microR-147b represses the proliferation and invasion of thyroid carcinoma cells by inhibiting Wnt/β-catenin signaling via targeting SOX15.
Xu C; Liu J; Yao X; Bai Y; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Guo L; Zheng Z; Zhang S
Mol Cell Endocrinol; 2020 Feb; 501():110662. PubMed ID: 31760045
[TBL] [Abstract][Full Text] [Related]
31. Cytosolic Cadherin 4 promotes angiogenesis and metastasis in papillary thyroid cancer by suppressing the ubiquitination/degradation of β-catenin.
Wu L; Xiao J; Yi D; Ding H; Wang R; Duan Z; Liu Z; Shi X; Shen M; Sang J
J Transl Med; 2024 Feb; 22(1):201. PubMed ID: 38402159
[TBL] [Abstract][Full Text] [Related]
32. MiR-200c promotes proliferation of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
Ren ZF; Du MF; Fu H; Liu J; Xia FY; Du HN; Liu N
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5512-5518. PubMed ID: 32495886
[TBL] [Abstract][Full Text] [Related]
33. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-625-3p promotes the proliferation, migration and invasion of thyroid cancer cells by up-regulating astrocyte elevated gene 1.
Fang L; Kong D; Xu W
Biomed Pharmacother; 2018 Jun; 102():203-211. PubMed ID: 29558717
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2.
Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195
[TBL] [Abstract][Full Text] [Related]
36. Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling.
Zhu J; Li X; Zhang S; Liu J; Yao X; Zhao Q; Kou B; Han P; Wang X; Bai Y; Zheng Z; Xu C
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S87-S95. PubMed ID: 34219514
[TBL] [Abstract][Full Text] [Related]
37. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
[TBL] [Abstract][Full Text] [Related]
38. WNT10A/β‑catenin pathway in tumorigenesis of papillary thyroid carcinoma.
Dong T; Zhang Z; Zhou W; Zhou X; Geng C; Chang LK; Tian X; Liu S
Oncol Rep; 2017 Aug; 38(2):1287-1294. PubMed ID: 28677753
[TBL] [Abstract][Full Text] [Related]
39. β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in
Zou M; Al-Yahya S; Al-Alwan M; BinEssa HA; Khabar KSA; Almohanna F; Assiri AM; Altaweel A; Qattan A; Meyer BF; Alzahrani AS; Shi Y
Front Immunol; 2023; 14():1171816. PubMed ID: 37483610
[TBL] [Abstract][Full Text] [Related]
40. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
Xiao X; Li L; Cui JC; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]